LeMaitre Vascular, Inc. reported first-quarter 2026 earnings of $0.68 per share, exceeding analyst estimates of $0.66 [2].
The results demonstrate the company's ability to scale operations and increase profitability through significant operating leverage during the start of the fiscal year.
Based in Burlington, Massachusetts, the company saw sales growth of 11% [1]. This performance represents a notable increase over the first quarter of 2025, when earnings per share stood at $0.48 [2].
Alongside the financial results, LeMaitre Vascular declared a quarterly dividend of $0.25 per share [4]. The dividend is payable on June 4, 2026, to shareholders of record as of May 21, 2026 [5]. This distribution results in a forward dividend yield of 0.89% [7].
The company also provided forward-looking guidance for its financial performance. For the current quarter, revenue guidance is set between $70.5 million and $72.5 million [8].
For the full year, LeMaitre Vascular expects revenue to fall between $277 million and $283 million [10]. The company projected full-year earnings per share to range from $2.93 to $3.08 [9].
“LeMaitre Vascular reported first-quarter 2026 earnings of $0.68 per share”
The beat on earnings and the double-digit sales growth suggest that LeMaitre Vascular is successfully expanding its market share in the vascular medical device sector. By providing specific full-year guidance and maintaining a consistent dividend, the company is signaling stability to investors despite the inherent volatility of the healthcare technology market.
